ABOUT
Our Members
Board of Directors
Staff
Our Support
Contact Us
Issue Areas
COVID-19
Health Equity, Diversity, & Inclusion
Reducing Health Costs
Health Care Reform
Value
Real-World Evidence
Patient Engagement
FDA Regulations
Medicaid Unwinding Resources
Resources
Member Resources
Fair-Market Value Calculator
Patient Experience Mapping
A Blueprint for Developing Patient-Centered Core Impact Sets (PC-CIS)
Meetings & Events
Newsroom
Letters & Comments
Research Briefs
Job Bank
Education
Real-World Evidence Classroom
Value Classroom
Patient-Focused Medical Product Development Series
Clinical Outcome Assessment Series
Health Literacy Series
Health Care Quality
Webinars
Blog
Membership
Our Members
Standards of Excellence
CAE Approved Provider
Join Us
Accessibility Tools
Toggle navigation
letters & comments
NHC Comments on HHS Notice of Benefit and Payment Parameters for 2023
01/27/2022
Read More
Letter of Support for Dr. Robert Califf FDA Commissioner Nominee
12/13/2021
Read More
NHC Comments on FDA-2020-D-2316 for Benefit-Risk Assessment for New Drug and Biological Products; Draft Guidance for Industry
11/29/2021
Read More
NHC RWE, EHR and Medical Claims Comments
11/29/2021
Read More
NHC Comments on PDUFA Reauthorization Performance Goals and Procedures FY 2023-2027
10/29/2021
Read More
CMS Physician Fee Schedule Proposed Rule
09/13/2021
Read More
Recommendations to Congress for Reconciliation Legislation
09/08/2021
Read More
Patient-Centered Outcomes Research Institute (PCORI) National Health Priorities
08/27/2021
Read More
Cures 2.0 Discussion Draft
08/26/2021
Read More
« Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
Next »
